和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02256 和誉-B

已收盘 12-08 16:08:10

14.250

+0.050

+0.35%

最高14.390	最低13.660	成交量198.24万
今开14.200	昨收14.200	日振幅5.14%
总市值95.76亿	流通市值95.76亿	总股本6.72亿
成交额2,778万	换手率0.30%	流通股本6.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":14.25,"timestamp":1765181290002,"preClose":14.2,"halted":0,"volume":1982408,"delay":0,"floatShares":672000000,"shares":672000000,"eps":0.049145295065003765,"marketStatus":"已收盘","change":0.05,"latestTime":"12-08 16:08:10","open":14.2,"high":14.39,"low":13.66,"amount":27780414,"amplitude":0.051408,"askPrice":14.25,"askSize":31000,"bidPrice":13.98,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":0.24517160909041394,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765243800000},"marketStatusCode":5,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":14.2,"openAndCloseTimeList":[[1765157400000,1765166400000],[1765170000000,1765180800000]],"volumeRatio":1.510349,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02256/tweets","defaultTab":"tweets","newsList":[{"id":"2589024333","title":"和誉-B12月08日获主力加仓126.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589024333","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589024333?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181734,"startTime":"0","endTime":"0","summary":"12月08日, 和誉-B股价涨0.35%，报收14.25元，成交金额2778.0万元，换手率0.29%，振幅5.14%，量比1.51。和誉-B今日主力资金净流入126.2万元，连续5日净流入，上一交易日主力净流入180.0万元。该股近5个交易日上涨0.34%，主力资金累计净流入549.1万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出352.2万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208161751a43aefe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208161751a43aefe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2778985437.USD","BK1161","LU2476274308.USD","LU2476274720.SGD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU2488822045.USD","IE00B543WZ88.USD","02256"],"gpt_icon":0},{"id":"2589801094","title":"和誉-B(02256)：和誉医药于ESMO Asia 2025公布口服PD-L1抑制剂ABSK043联合 EGFR抑制剂伏美替尼治疗NSCLC的II期临床初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2589801094","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589801094?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:06","pubTimestamp":1765152368,"startTime":"0","endTime":"0","summary":"数据显示，ABSK043与伏美替尼的“靶免联合”方案展现出良好的安全性和耐受性。研究结果显示，ABSK043联合伏美替尼表现出可控的安全性和良好的耐受性。剂量递增阶段的研究结果表明，ABSK043联合伏美替尼不仅安全性可控、耐受性良好，还展现出令人鼓舞的初步抗肿瘤活性。上述积极结果为正在开展的剂量扩展阶段奠定了基础，该阶段将评估ABSK043联合伏美替尼作为一线疗法，用于治疗初治的EGFR突变、PD-L1阳性的NSCLC患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","159938","BK4023","LU2778985437.USD","09939","LU1169589451.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2476274720.SGD","LU2488822045.USD","LU2476274308.USD","PD","02256","BK1161","BK1574","IE00B5MMRT66.SGD","LU1169590202.USD"],"gpt_icon":0},{"id":"2589905855","title":"每日卖空追踪 | 和誉-B 12月04日卖空量成交1.4万股，卖空比例为1.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589905855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589905855?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837029,"startTime":"0","endTime":"0","summary":"和誉-B北京时间12月04日，涨2.54%，卖空量成交1.4万股，较上一交易日减少95.02%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163440978f8817&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163440978f8817&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2778985437.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU2488822045.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","02256"],"gpt_icon":0},{"id":"2589855922","title":"和誉-B12月04日获主力加仓62.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589855922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589855922?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836146,"startTime":"0","endTime":"0","summary":"12月04日, 和誉-B股价涨2.54%，报收14.15元，成交金额1384.9万元，换手率0.15%，振幅2.90%，量比0.72。和誉-B今日主力资金净流入62.2万元，连续3日净流入，上一交易日主力净流入139.7万元。该股近5个交易日下跌2.76%，主力资金累计净流入203.8万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出731.7万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162000952a735a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162000952a735a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2778985437.USD","LU2488822045.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","BK1161","LU2476274720.SGD","LU2476274308.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2588048711","title":"决胜港股升浪・致敬卓越力量，“第十届智通财经资本市场年会暨上市公司颁奖盛典”25项大奖揭晓!","url":"https://stock-news.laohu8.com/highlight/detail?id=2588048711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588048711?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:21","pubTimestamp":1764760876,"startTime":"0","endTime":"0","summary":"2025年12月3日，由国内领先的港美股资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办、财经公关综合服务提供商冬日暖阳 Donova 独家承办的 “第十届智通财经资本市场年会暨上市公司颁奖盛典” 在深圳盛大启幕。荣耀加冕：231 家企业及管理者斩获 25 项年度大奖当晚的颁奖典礼星光熠熠，各项大奖实至名归。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377197.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627","09699","02556","00017","02498","00363","00875","02256","00460","00135","00777","00861","00960","00136","00656","02419","00267","00992","02511","02525","00305","00384","00699","00020","02121","00382","00867","06160","02142","00999","00826","00300","01070","01833","02105","02279","00512","00003","02380","09678","00302","00855","00666","00451","00798","00884","01093","09878"],"gpt_icon":1},{"id":"1130314196","title":"和誉（02256）更新2025年11月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1130314196","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130314196?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:04","pubTimestamp":1764752694,"startTime":"0","endTime":"0","summary":"和誉开曼有限责任公司于2025年12月3日发布2025年11月股份变动月报表，报告期为2025年11月1日至11月30日。数据显示，公司注册股本维持5,000,000,000股，面值0.00001美元，总额50,000美元。期末已发行股份数量仍为672,361,350股，库藏股份7,744,000股，总计680,105,350股，较上月底并无变动。报告期内，公司并未新增发行或注销股份，亦无股票期权行使及股权激励计划下的股份变动。截至2025年11月30日，公司整体股本结构保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"gpt_icon":0},{"id":"2588107984","title":"每日卖空追踪 | 和誉-B 12月03日卖空量成交9万股，卖空比例为3.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588107984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588107984?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750626,"startTime":"0","endTime":"0","summary":"和誉-B北京时间12月03日，跌3.9%，卖空量成交9万股，较上一交易日增加55.17%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163426a7210f15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163426a7210f15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5MMRT66.SGD","LU2778985437.USD","LU2488822045.USD","BK1161","LU2476274308.USD","02256","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2588079871","title":"和誉-B盘中异动 下午盘股价大跌5.22%报13.610港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588079871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588079871?lang=zh_cn&edition=full","pubTime":"2025-12-03 13:37","pubTimestamp":1764740230,"startTime":"0","endTime":"0","summary":"2025年12月03日下午盘13时37分，和誉-B股票出现异动，股价快速下挫5.22%。截至发稿，该股报13.610港元/股，成交量78.6万股，换手率0.12%，振幅5.29%。资金方面，该股资金流入368.333万港元，流出610.161万港元。和誉-B股票所在的生物技术行业中，整体跌幅为2.06%。该公司拥有两款核心候选产品ABSK011和 ABSK091,以及12款其他在研产品。ABSK091 是一种分子靶向候选产品,也是 FGFR亚型 1、2和3的强效和选择性抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203133710a720b7d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203133710a720b7d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BPRC5H50.USD","02256","BK1161","LU2476274308.USD","LU2488822045.USD","IE00B5MMRT66.SGD","LU2476274720.SGD","LU2778985437.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2588097666","title":"默克中国换帅；和誉医药KRAS G12D抑制剂在美国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2588097666","media":"氨基观察","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588097666?lang=zh_cn&edition=full","pubTime":"2025-12-03 10:39","pubTimestamp":1764729593,"startTime":"0","endTime":"0","summary":"默克中国人事调整。12月2日，和誉医药宣布，口服小分子KRAS G12D抑制剂ABSK141新药临床试验申请获FDA批准。2）默克中国换帅12月2日，默克中国宣布，现任默克全球心血管代谢与内分泌业务高级副总裁Andre Musto（穆安德）将出任默克中国医药健康业务新任董事总经理，任命将于2026年2月1日正式生效。4）凌科药业TYK2变构抑制剂在美国获批临床12月2日，凌科药业宣布，其自主研发的创新TYK2变构抑制剂LNK01006已获美国FDA批准开展临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512031105219527eebc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512031105219527eebc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","LU2778985437.USD","IE00BPRC5H50.USD","BK1515","LU2476274308.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU2476274720.SGD","02256","IE00B543WZ88.USD","BK1574"],"gpt_icon":0},{"id":"2588705006","title":"和誉药业：ABSK141新药临床申请获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2588705006","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588705006?lang=zh_cn&edition=full","pubTime":"2025-12-01 18:03","pubTimestamp":1764583425,"startTime":"0","endTime":"0","summary":"【和誉药业附属公司新药临床试验申请获美国FDA批准】12月1日，和誉药业公告，其附属公司上海和誉生物医药科技有限公司透露，口服小分子KRASG12D抑制剂ABSK141的新药临床试验申请，已获美国食品药品监督管理局批准。 ABSK141是口服、高活性、高选择性小分子KRASG12D抑制剂，用于治疗携带KRASG12D突变的晚期实体瘤患者。 此次获批的是开放标签I/II期临床研究，旨在评估ABSK141在相关患者中的安全性、耐受性、有效性和药代动力学。本文由 AI 算法生成，仅作参考，不涉投资建议，使用风险自担","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201195011a71cd89b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201195011a71cd89b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","02256","BK1161","LU2476274308.USD","LU2778985437.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2588210723","title":"和誉-B(02256)：口服小分子KRAS G12D抑制剂 ABSK141的IND申请获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2588210723","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588210723?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:40","pubTimestamp":1764582054,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，公司的附属公司上海和誉生物医药科技有限公司宣布，一种用于治疗携带KRAS G12D突变的晚期实体瘤患者的口服、高活性、高选择性小分子KRAS G12D抑制剂ABSK141的新药临床试验(IND)申请已获得美国食品药品监督管理局(FDA)批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2476274720.SGD","LU2778985437.USD","IND","02256","IE00B5MMRT66.SGD","LU2488822045.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","BK1161","LU2476274308.USD"],"gpt_icon":0},{"id":"2588706887","title":"每日卖空追踪 | 和誉-B 12月01日卖空量成交3.9万股，卖空比例为3.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588706887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588706887?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577828,"startTime":"0","endTime":"0","summary":"和誉-B北京时间12月01日，涨1.4%，卖空量成交3.9万股，较上一交易日减少72.34%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163356a4c55127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163356a4c55127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2488822045.USD","IE00B5MMRT66.SGD","LU2476274308.USD","BK1161","IE00B543WZ88.USD","LU2778985437.USD","IE00BPRC5H50.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2587267756","title":"每日卖空追踪 | 和誉-B 11月28日卖空量成交5.6万股，卖空比例为4.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587267756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587267756?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:30","pubTimestamp":1764318626,"startTime":"0","endTime":"0","summary":"和誉-B北京时间11月28日，跌1.38%，卖空量成交5.6万股，较上一交易日减少56.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164428978469b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164428978469b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","LU2476274308.USD","LU2778985437.USD","02256","BK1161","LU2476274720.SGD","LU2488822045.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2586220750","title":"每日卖空追踪 | 和誉-B 11月27日卖空量成交5.4万股，卖空比例为3.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586220750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586220750?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232225,"startTime":"0","endTime":"0","summary":"和誉-B北京时间11月27日，涨1.97%，卖空量成交5.4万股，较上一交易日减少62.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127163615a714d32e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127163615a714d32e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2778985437.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","LU2476274308.USD","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2586090425","title":"和誉-B11月25日主力净流出748.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2586090425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586090425?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:15","pubTimestamp":1764058512,"startTime":"0","endTime":"0","summary":"11月25日, 和誉-B股价跌1.52%，报收14.21元，成交金额6088.3万元，换手率0.63%，振幅4.09%，量比1.02。和誉-B今日主力资金净流出748.0万元，上一交易日主力净流出0万元。该股近5个交易日上涨4.50%，主力资金累计净流出847.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1740.9万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125161538a7101be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125161538a7101be1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2778985437.USD","IE00B5MMRT66.SGD","LU2476274308.USD","IE00B543WZ88.USD","LU2476274720.SGD","IE00BPRC5H50.USD","02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2585465727","title":"每日卖空追踪 | 和誉-B 11月24日卖空量成交7.4万股，卖空比例为1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585465727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585465727?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:30","pubTimestamp":1763973028,"startTime":"0","endTime":"0","summary":"和誉-B北京时间11月24日，涨10.41%，卖空量成交7.4万股，较上一交易日减少75.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163347a4b6a4d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163347a4b6a4d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BPRC5H50.USD","BK1161","02256","LU2476274308.USD","LU2488822045.USD","IE00B543WZ88.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","LU2778985437.USD"],"gpt_icon":0},{"id":"2586144596","title":"和誉-B盘中异动 大幅上涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586144596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586144596?lang=zh_cn&edition=full","pubTime":"2025-11-24 13:56","pubTimestamp":1763963810,"startTime":"0","endTime":"0","summary":"2025年11月24日下午盘13时56分，和誉-B股票出现波动，股价急速上涨5.43%。和誉-B股票所在的生物技术行业中，整体涨幅为3.12%。其相关个股中，银诺医药-B、泰格医药、拨康视云-B涨幅较大，振幅较大的相关个股有华康生物医学、银诺医药-B、中生北控生物科技，振幅分别为30.39%、28.31%、16.79%。该公司拥有两款核心候选产品ABSK011和 ABSK091,以及12款其他在研产品。ABSK091 是一种分子靶向候选产品,也是 FGFR亚型 1、2和3的强效和选择性抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124135650a4b652c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124135650a4b652c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5MMRT66.SGD","LU2778985437.USD","LU2488822045.USD","BK1161","LU2476274308.USD","02256","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2584900001","title":"港股异动 | 和誉-B(02256)尾盘涨超4% 公司展示匹米替尼临床III期MANEUVER研究长期疗效和安全性数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2584900001","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584900001?lang=zh_cn&edition=full","pubTime":"2025-11-20 14:54","pubTimestamp":1763621660,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和誉-B(02256)尾盘涨超4%，截至发稿，涨3.9%，报14.13港元，成交额4541万港元。消息面上，和誉公布，其附属和誉医药在结缔组织肿瘤学会(CTOS)2025年会上以壁报形式，展示匹米替尼(pimicotinib/ABSK021)治疗腱鞘巨细胞瘤(TGCT)患者的全球III期MANEUVER研究的长期疗效、安全性及患者报告结果数据。该长期分析显示，持续接受匹米替尼治疗可为TGCT患者在肿瘤缓解方面带来疗效持续提升与患者报告结果(包括疼痛与功能)的进一步改善，同时维持可接受的安全性，强化匹米替尼在适合患者中的长期应用潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","LU2476274720.SGD","IE00B543WZ88.USD","02256","LU2476274308.USD","LU2778985437.USD","IE00B5MMRT66.SGD","LU2488822045.USD","BK1161","IE00BPRC5H50.USD","III"],"gpt_icon":0},{"id":"2584590553","title":"每日卖空追踪 | 和誉-B 11月19日卖空量成交8.7万股，卖空比例为3.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584590553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584590553?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:30","pubTimestamp":1763541026,"startTime":"0","endTime":"0","summary":"和誉-B北京时间11月19日，跌1.31%，卖空量成交8.7万股，较上一交易日减少46.3%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163359950e05ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163359950e05ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","IE00BPRC5H50.USD","LU2476274720.SGD","LU2476274308.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU2778985437.USD","IE00B543WZ88.USD","02256"],"gpt_icon":0},{"id":"2584023605","title":"决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴","url":"https://stock-news.laohu8.com/highlight/detail?id=2584023605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584023605?lang=zh_cn&edition=full","pubTime":"2025-11-18 08:53","pubTimestamp":1763427196,"startTime":"0","endTime":"0","summary":"由港美股第一资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办，“冬日暖阳” 独家承办，S&P Global Market Intelligence、CITIZEN支持的“第十届智通财经资本市场年会”将于2025年12月3-5日联动深圳与香港两地举行。本届年会以\"决胜港股升浪·牛启东方2026\"为主题，设置六大核心议程，汇聚全球资本力量，共探宽松周期尾声的领涨赛道与中国资产长期增长潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00855","02431","02177","01228","09878","02488","01318","02509","06682","09678","02511","06996","02268","02157","00699","00196","00861","06660","03658","06608","06609","00382","02142","02256","02453","09959","00826","01164","00305","02420","02587","00290","00302","02279","02167","00363","09911","00604","01167","02105","02096","09996","00867","01333","00552","02627","02561","02670","02171","00003"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbisko.com","stockEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0261},{"period":"3month","weight":-0.2202},{"period":"6month","weight":0.4807},{"period":"1year","weight":1.9895},{"period":"ytd","weight":2.087}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和誉开曼有限责任公司是一家临床阶段生物制药公司。该公司致力于发现和开发创新差异化的小分子肿瘤疗法。该公司拥有两款核心候选产品ABSK011和 ABSK091，以及12款其他在研产品。ABSK011是一种强效且高选择性的成纤维细胞生长因子受体4(FGFR4) 小分子抑制剂。ABSK091 是一种分子靶向候选产品，也是 FGFR亚型 1、2和3的强效和选择性抑制剂。该公司的产品主要用于肝细胞癌(HCC)、尿路上皮癌(UC) 和胃癌(GC)。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.143011},{"month":2,"riseRate":0.75,"avgChangeRate":0.046576},{"month":3,"riseRate":0.5,"avgChangeRate":0.054417},{"month":4,"riseRate":0.25,"avgChangeRate":-0.010041},{"month":5,"riseRate":0.25,"avgChangeRate":0.029375},{"month":6,"riseRate":0.5,"avgChangeRate":0.006841},{"month":7,"riseRate":0.75,"avgChangeRate":0.047273},{"month":8,"riseRate":0.5,"avgChangeRate":0.114048},{"month":9,"riseRate":0.75,"avgChangeRate":0.043844},{"month":10,"riseRate":0.5,"avgChangeRate":-0.043137},{"month":11,"riseRate":0.6,"avgChangeRate":0.159978},{"month":12,"riseRate":0,"avgChangeRate":-0.076051}],"exchange":"SEHK","name":"和誉-B","nameEN":"ABBISKO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和誉-B,02256,和誉-B股票,和誉-B股票老虎,和誉-B股票老虎国际,和誉-B行情,和誉-B股票行情,和誉-B股价,和誉-B股市,和誉-B股票价格,和誉-B股票交易,和誉-B股票购买,和誉-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}